| 764 |
209: Peptide Oxidation |
719: Increase, hepatocellular adenomas and carcinomas |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 765 |
209: Peptide Oxidation |
768: Increase, Cytotoxicity |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 922 |
209: Peptide Oxidation |
177: Increase, Mitochondrial dysfunction |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 923 |
209: Peptide Oxidation |
87: Release, Cytokine |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 932 |
209: Peptide Oxidation |
357: Cholestasis, Pathology |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 948 |
209: Peptide Oxidation |
926: Oxidation, Glutathione |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 980 |
209: Peptide Oxidation |
935: Decrease, GTPCH-1 |
Nov 29, 2016 |
Sep 28, 2017 |
1 AOP
|
| 992 |
209: Peptide Oxidation |
973: Decrease, AKT/eNOS activity |
Nov 29, 2016 |
Oct 16, 2017 |
1 AOP
|
| 1237 |
209: Peptide Oxidation |
1172: Increased activation, Nuclear factor kappa B (NF-kB) |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1379 |
209: Peptide Oxidation |
1292: Activation, JNK |
Feb 15, 2017 |
Feb 15, 2017 |
1 AOP
|
| 1467 |
209: Peptide Oxidation |
1194: Increase, DNA Damage |
Apr 15, 2017 |
Apr 15, 2017 |
None
|
| 1698 |
209: Peptide Oxidation |
927: S-Glutathionylation, eNOS |
Nov 16, 2017 |
Nov 20, 2017 |
1 AOP
|
| 2516 |
1947: Pericyte dysfunction |
1913: Endothelial cell dysfunction |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 395 |
228: demethylation, PPARg promoter |
408: reduction in ovarian granulosa cells, Aromatase (Cyp19a1) |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 411 |
228: demethylation, PPARg promoter |
54: Up Regulation, CD36 |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 487 |
228: demethylation, PPARg promoter |
457: Activation, SREBF1 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1402 |
228: demethylation, PPARg promoter |
1301: Activation, SREBP-1 |
Apr 12, 2017 |
Apr 12, 2017 |
None
|
| 1424 |
228: demethylation, PPARg promoter |
116: Activation, FAS |
Apr 13, 2017 |
Apr 13, 2017 |
None
|
| 1608 |
228: demethylation, PPARg promoter |
1028: Activation of specific nuclear receptors, PPAR-gamma activation |
Jul 24, 2017 |
Jul 24, 2017 |
1 AOP
|
| 1659 |
228: demethylation, PPARg promoter |
465: Increased, FA Influx |
Aug 31, 2017 |
Aug 31, 2017 |
1 AOP
|
| 2988 |
228: demethylation, PPARg promoter |
2165: Activation of PPAR |
Aug 20, 2023 |
Aug 20, 2023 |
1 AOP
|
| 1125 |
1086: persistent, cytotoxicity (pleura or peritoneum) |
1087: Increased, inflammation |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 3261 |
1086: persistent, cytotoxicity (pleura or peritoneum) |
1392: Increase, Oxidative Stress |
Jul 3, 2024 |
Jul 3, 2024 |
1 AOP
|
| 1377 |
1289: Perturbation of cholesterol |
1291: Hepatotoxicity |
Feb 15, 2017 |
Feb 15, 2017 |
1 AOP
|
| 3427 |
2288: Phosphodiesterase (PDE) |
2284: Intracellular cAMP |
Nov 22, 2024 |
Nov 22, 2024 |
None
|